Modeling and Simulation - PK/PD Archives

Blog

Certainty US 2026 recap: advancing model-informed drug development right from the start

This blog shares the highlights of our US Certainty event and explains how AI-enabled approaches…

Certara2026 年 5 月 26 日

Publication

尼拉帕利（Niraparib）群体药代动力学建模以评估不同吸收模型

This publication describes the development of an updated population pharmacokinetic (PopPK) model for niraparib, a…

Certara2026 年 5 月 21 日

On-Demand Webinar

Pharmacometrics Under Pressure Part 3: The Wall: When the Model Gets Harder Than Planned

Learn how Phoenix NLME and RsNLME support advanced PK/PD workflows and complex pharmacometric modeling through…

Certara2026 年 5 月 20 日

On-Demand Webinar

Pharmacometrics Under Pressure Part 2 – The Steady Miles: Project-Grade PMx Without Losing Pace

See how Phoenix NLME and RsNLME support scalable and manageable workflows as project demands evolve.

Danielle Pillsbury2026 年 5 月 8 日

Blog

What We Learned at Phoenix UGM at Certainty 2026 About the Future of PK/PD

JTVCdGVhbV9qdW1wX2xpc3QlNUQ= 2026 年 5 月 8 日 At Certainty 2026, the Phoenix User Group Meeting brought together scientists,…

Certara2026 年 5 月 8 日

Guide

Designing Drug Development Programs for Reimbursement Success

Download the guide to learn how model-informed drug development, QSP, and MBMA help align with…

Certara2026 年 5 月 7 日

On-Demand Webinar

Pharmacometrics Under Pressure: The Quantitative Clinical Pharmacology Sprint

Explore how Phoenix NLME and RsNLME support early phase clinical pharmacology workflows where speed, clarity,…

Certara2026 年 5 月 6 日

Blog

GxP Compliance in the Cloud: What IT Teams Need to Rethink

Learn how GxP validation works in modern SaaS and cloud environments, with best practices for…

Certara2026 年 5 月 4 日

Webinar

Allometric Approach in pharmacokinetics when and how to use it

Danielle Pillsbury2026 年 4 月 28 日

Blog

From Models to Impact: What QSPC 2026 Revealed About the Future of Drug Development

Explore Certara’s insights from QSPC 2026, including virtual patients, regulatory adoption, AI in QSP, and…

Certara2026 年 4 月 28 日

Modeling and Simulation – PK/PD

Certainty US 2026 recap: advancing model-informed drug development right from the start

尼拉帕利（Niraparib）群体药代动力学建模以评估不同吸收模型

Pharmacometrics Under Pressure Part 3: The Wall: When the Model Gets Harder Than Planned

Pharmacometrics Under Pressure Part 2 – The Steady Miles: Project-Grade PMx Without Losing Pace

What We Learned at Phoenix UGM at Certainty 2026 About the Future of PK/PD

Designing Drug Development Programs for Reimbursement Success

Pharmacometrics Under Pressure: The Quantitative Clinical Pharmacology Sprint

GxP Compliance in the Cloud: What IT Teams Need to Rethink

Allometric Approach in pharmacokinetics when and how to use it

From Models to Impact: What QSPC 2026 Revealed About the Future of Drug Development

订阅时事通讯

快捷链接

解决方案

联系我们